Detect overdose exposure.
Semi-Quantitative Immunoassay/Gas Chromatography-Mass Spectrometry/ Liquid Chromatography-Tandem Mass Spectrometry
Transfer 6 mL serum to ARUP Standard Transport Tubes. (Min: 5.5 mL)
Avoid use of separator tubes and gels.
After separation from cells: Ambient: 48 hours; Refrigerated: 1 week; Frozen: 2 months
The following drugs or drug classes may be detected: acetaminophen, barbiturates, benzodiazepines, carbamazepine, carisoprodol, disopyramide, meprobamate, phenytoin, primidone, salicylate, theophylline, tricyclic and other antidepressants.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
This test is not optimized for most drugs of abuse (amphet/methamphet, barbiturates, benzodiazepines, cocaine, methadone, opiates, propoxyphene, PCP, THC); instead, refer to Drug Screen 9 Panel, Serum or Plasma, Immunoassay Screen with Reflex to Mass Spectrometry Confirmation/Quantitation (ARUP test code 0092420).
|Component Test Code*||Component Chart Name||LOINC|
|0090499||Drug Screen (Nonforensic), Serum||20785-2|
- Drug Analysis
- Multiple Drug Analysis, Blood Screen
- Tox Screen